MARKET WIREYahoo • 2d ago
Establishment Labs Holdings Inc. Q3 2026 Earnings Call SummaryMoby summary of Establishment Labs Holdings Inc.'s Q3 2026 earnings call
Why ESTA Stock slipped -0.81% Today — RQD Quant Desk Flash
$68.41 -0.81% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
Establishment Labs Holdings Inc. (ESTA) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $2.04B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-10.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ESTA)Realized 20D OHLCV Swing Band: ±12.5%
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ESTA Stock slipped -0.81% Today — RQD Quant Desk Flash
Establishment Labs Holdings Inc. (ESTA) slipped -0.81% to $68.41, trading at 42% of its 52-week range ($47 – $97.59). Stretched risk/reward at current multiples (-16% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 42% of its 52-week range ($47 – $97.59) with RSI-14 at 44.9 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $68.41 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 69.3% gross margin and $0 annual free cash flow.
Live ESTA Headlines & Catalysts
MARKET WIREBenzinga • 3d ago
BTIG Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $93BTIG analyst Sam Eiber maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and lowers the price target from $103 to $93.
CATALYSTYahoo • 3d ago
What Establishment Labs (ESTA) Said on Its Q3 Earnings CallEstablishment Labs (NASDAQ:ESTA) reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the company generated pos
CATALYSTYahoo • 3d ago
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue EstimatesEstablishment Labs (ESTA) delivered earnings and revenue surprises of -29.63% and +8.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
MARKET WIRESeekingAlpha • 3d ago
Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call TranscriptEstablishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDTCompany ParticipantsMalavika William - VP, Global Head of...
MARKET WIREYahoo • 3d ago
Establishment Labs® Reports Third Quarter 2026 Financial ResultsNEW YORK, October 29, 2026--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, to
MARKET WIREBenzinga • 3d ago
Establishment Labs Hldgs Q3 2026 Earnings Call TranscriptEstablishment Labs Hldgs (NASDAQ:ESTA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by
MARKET WIREBenzinga • 3d ago
Establishment Labs Hldgs FY2026 Revenue expected to be more than $274.000M vs $270.215M EstEstablishment Labs Hldgs (NASDAQ:ESTA) FY2026 Revenue expected to be more than $274.000M vs $270.215M Est
RISK WATCHBenzinga • 3d ago
Establishment Labs Hldgs Q3 EPS $(0.35) Misses $(0.26) Estimate, Sales $71.993M Beat $66.460M EstimateEstablishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.26) by 34.62 percent. This is a 7.89 percent increase over losses of $(0.38) per
MARKET WIREBenzinga • 6d ago
TD Cowen Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $95TD Cowen analyst Joshua Jennings maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and lowers the price target from $117 to $95.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ESTA)
- ✓Walkthrough of ESTA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ESTA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -0.32%▲ RESISTANCE BREAKOUT
2026-10-30O $67.38H $68.41L $60.25C $68.41VOL 1.03M
RES: $61.19SUP: $50.38SMA50: $67.06SMA200: $72.38
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ESTA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +27.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ESTA today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ESTA. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ESTA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ESTA)
Health Care Rank #835 of 1016
⚔️ CDRE vs ESTA Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ESTA vs. CDRE, ENOV, AVR, MSA)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Establishment Labs Holdings Inc. (ESTA) ranks #835 by composite RQD confidence (34/100, grade E) and #259 by equity capitalization ($2.04B). Within this direct 5-issuer industry benchmark cohort, MSA leads on earnings valuation at 24.8x trailing P/E, while MSA leads on capital efficiency and profitability with 16.6% ROIC and 46.5% gross margin. CDRE currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with ESTA at 34/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ESTA
ACTIVE
Establishment Labs Holdings Inc. | E | 34/100 | — | 69.3% | -15.8% | -0.81% | $2.04B | Benchmark Subject |
| CDRE Cadre Holdings Inc. | B | 74/100 | 30.2x | 42.5% | 11.0% | +3.81% | $1.33B | /cdre-vs-esta → |
| ENOV Enovis Corporation | D | 46/100 | — | 59.8% | -32.7% | +4.11% | $1.32B | /enov-vs-esta → |
| AVR Anteris Technologies Global Corp. | D- | 36/100 | — | 70.3% | -35.0% | +5.25% | $625.9M | /avr-vs-esta → |
| MSA MSA Safety Incorporated | B | 72/100 | 24.8x | 46.5% | 16.6% | +1.13% | $6.91B | /msa-vs-esta → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001688757In its most recent audited fiscal period (FY2025, filed 2025-12-31), Establishment Labs Holdings Inc. (ESTA) reported GAAP revenue of $211.1M (+27.1% vs. FY2024 revenue of $166.0M , and +27.8% cumulative change since FY2023) , GAAP net income of -$51.1M, operating cash flow of -$50.9M, and free cash flow of -$56.9M (+11.9% YoY). On the balance sheet, ESTA closed FY2025 with $357.2M in total assets against $247.5M in total debt (Altman Z-Score: 2.52, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $211.1M | -$51.1M | -$50.9M | -$56.9M | $357.2M | $247.5M |
| FY2024 (FY) | 2024-12-31 | $166.0M | -$84.6M | -$58.5M | -$64.6M | $346.8M | $219.6M |
| FY2023 (FY) | 2023-12-31 | $165.2M | -$78.5M | -$88.5M | -$88.5M | — | — |
3. ESTA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ESTA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Establishment Labs Holdings Inc. (NASDAQ: ESTA) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $68.41 (-0.81% 1D, market cap $2.04B). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, ESTA ranks #835 in composite RQD confidence.
How does ESTA compare to CDRE and ENOV in the Health Care sector?
Within the Health Care sector (Industrial Specialties), ESTA carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 69.3%, and ROIC of -15.8%. By comparison, CDRE (Cadre Holdings Inc.) holds a B grade (74/100 RQD, P/E 30.2x, ROIC 11.0%, cap $1.33B) and ENOV (Enovis Corporation) posts a D grade (46/100 RQD, P/E N/A, ROIC -32.7%, cap $1.32B). Among the 5-stock peer group, MSA leads on earnings multiple (24.8x) while MSA leads on capital efficiency (16.6% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ESTA?
Per ESTA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001688757), Establishment Labs Holdings Inc. generated $211.1M in revenue (+27.1% YoY), -$51.1M in net income, and -$56.9M in free cash flow against $357.2M in total assets and $247.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ESTA trading relative to its 50-day, 200-day, and 52-week technical levels?
ESTA last traded at $68.41 (-0.81% on volume of 1,043,253 shares), positioning the stock +2.01% above its 50-day simple moving average ($67.06) and -5.48% below its 200-day simple moving average ($72.38). Across its 52-week range of $47.00 to $97.59, ESTA sits at the 42.3% percentile with a 14-day RSI of 44.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($59.86 to $76.96).
ESTA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ESTA stock moving today?
Why ESTA Stock slipped -0.81% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-16% return on capital) under elevated 10-year interest-rate pressure.